1 |
Riquet M,Arame A,Le Pimpec Barthes F.Non-small cell lung cancer invading the chest wall[J].Thorac Surg Clin,2010,20(4):519-527.
|
2 |
Wang L,Yan X,Zhao J,et al.Expert consensus on resection of chest wall tumors and chest wall reconstruction[J].Transl Lung Cancer Res,2021,10(11):4057-4083.
|
3 |
Yokoi K,Taniguchi T,Usami N,et al.Surgical management of locally advanced lung cancer[J].Gen Thorac Cardiovasc Surg,2014,62(9):522-530.
|
4 |
Downey RJ,Martini N,Rusch VW,et al.Extent of chest wall invasion and survival in patients with lung cancer[J].Ann Thorac Surg,1999,68(1):188-193.
|
5 |
仲佳.《CSCO非小细胞肺癌诊疗指南2021》更新要点解读[J].实用肿瘤杂志,2022,37(1):8-15.
|
6 |
Ucvet A,Yazgan S,Gursoy S,et al.Prognosis of Resected Non-small Cell Lung Cancer with Ipsilateral Pulmonary Metastasis[J].Thorac Cardiovasc Surg,2020,68(2):176-182.
|
7 |
Lee CY,Byun CS,Lee JG,et al.The prognostic factors of resected non-small cell lung cancer with chest wall invasion[J].World J Surg Oncol,2012,10:9.
|
8 |
Suzuki M,Yoshida S,Moriya Y,et al.Surgical outcomes of newly categorized peripheral T3 non-small cell lung cancers: comparisons between chest wall invasion and large tumors (>7 cm)[J].Interact Cardiovasc Thorac Surg,2010,11(4):420-424.
|
9 |
Voltolini L,Rapicetta C,Luzzi L,et al.Lung cancer with chest wall involvement: predictive factors of long-term survival after surgical resection[J].Lung Cancer,2006,52(3):359-364.
|
10 |
Coster JN,Groth SS.Surgery for Locally Advanced and Oligometastatic Non-Small Cell Lung Cancer[J].Surg Oncol Clin N Am,2020,29(4):543-554.
|
11 |
Facciolo F,Cardillo G,Lopergolo M,et al.Chest wall invasion in non-small cell lung carcinoma:a rationale for en bloc resection[J].J Thorac Cardiovasc Surg,2001,121(4):649-656.
|
12 |
Otsuka S,Hiraoka K,Ohtaka K,et al.Small-sized peripheral squamous cell lung carcinoma with chest wall invasion[J].Respir Med Case Rep,2022,36:101589.
|
13 |
Santos HT,Lopes AJ,Higa C,et al.Lung cancer with chest wall invasion:retrospective analysis comparing en-bloc resection and 'resection in bird cage’[J].J Cardiothorac Surg,2014,9:57.
|
14 |
Doddoli C,D’Journo B,Le Pimpec-Barthes F,et al.Lung cancer invading the chest wall: a plea for en-bloc resection but the need for new treatment strategies[J].Ann Thorac Surg,2005,80(6):2032-2040.
|
15 |
Hanagiri T,Shinohara S,Takenaka M,et al.Clinical Characteristics of Resected T3 Non-small Cell Lung Cancer Characterized by Parietal Pleural Invasion or Chest Wall Invasion[J].Indian J Surg,2014,76(5):354-358.
|
16 |
Akata S,Kajiwara N,Park J,et al.Evaluation of chest wall invasion by lung cancer using respiratory dynamic MRI[J].J Med Imaging Radiat Oncol,2008,52(1):36-39.
|
17 |
Tahiri M,Khereba M,Thiffault V,et al.Preoperative assessment of chest wall invasion in non-small cell lung cancer using surgeon-performed ultrasound[J].Ann Thorac Surg,2014,98(3):984-989.
|
18 |
Sripathi S,Mahajan A.Comparative study evaluating the role of color Doppler sonography and computed tomography in predicting chest wall invasion by lung tumors[J].J Ultrasound Med,2013,32(9):1539-1546.
|
19 |
Collaud S,Fadel E,Schirren J,et al.En Bloc Resection of Pulmonary Sulcus Non-small Cell Lung Cancer Invading the Spine: A Systematic Literature Review and Pooled Data Analysis[J].Ann Surg,2015,262(1):184-188.
|
20 |
Jones GD,Caso R,No JS,et al.Prognostic factors following complete resection of non-superior sulcus lung cancer invading the chest wall[J].Eur J Cardiothorac Surg,2020,58(1):78-85.
|
21 |
王磊,李靖,钟代星.胸壁肿瘤切除及胸壁重建手术中国专家共识(2018版)[J].中国胸心血管外科临床杂志,2019,26(1):1-7.
|
22 |
Kawaguchi K,Mori S,Usami N,et al.Preoperative evaluation of the depth of chest wall invasion and the extent of combined resections in lung cancer patients[J].Lung Cancer,2009,64(1):41-44.
|
23 |
张茂增,胡为才,姬弘涛.胸壁切除术和非胸壁切除术治疗非小细胞肺癌的效果对比[J].右江民族医学院学报,2020,42(2):212-215.
|
24 |
陈重.侵犯胸壁的非小细胞肺癌的外科治疗[J].河南医学研究,2012,21(3):285-286.
|
25 |
Scarnecchia E,Liparulo V,Capozzi R,et al.Chest wall resection and reconstruction for tumors: analysis of oncological and functional outcome[J].J Thorac Dis,2018,10(Suppl 16):S1855-S1863.
|
26 |
Lanuti M.Surgical Management of Lung Cancer Involving the Chest Wall[J].Thorac Surg Clin,2017,27(2):195-199.
|
27 |
Matsuoka H,Nishio W,Okada M,et al.Resection of chest wall invasion in patients with non-small cell lung cancer[J].Eur J Cardiothorac Surg,2004,26(6):1200-1204.
|
28 |
Magdeleinat P,Alifano M,Benbrahem C,et al.Surgical treatment of lung cancer invading the chest wall: results and prognostic factors[J].Ann Thorac Surg,2001,71(4):1094-1099.
|
29 |
Berry MF,Onaitis MW,Tong BC,et al.Feasibility of hybrid thoracoscopic lobectomy and en-bloc chest wall resection[J].Eur J Cardiothorac Surg,2012,41(4):888-892.
|
30 |
Demmy TL,Yendamuri S,Hennon MW,et al.Thoracoscopic maneuvers for chest wall resection and reconstruction[J].J Thorac Cardiovasc Surg,2012,144(3):S52-S57.
|
31 |
Muguruza I,Aranda JL,García-Yuste M.Treatment of lung cancer with chest wall invasion[J].Arch Bronconeumol,2011,47 Suppl 1:27-32.
|
32 |
Zhang Y,Li JZ,Hao YJ,et al.Sternal tumor resection and reconstruction with titanium mesh:a preliminary study[J].Orthop Surg,2015,7(2):155-160.
|
33 |
Weyant MJ,Bains MS,Venkatraman E,et al.Results of chest wall resection and reconstruction with and without rigid prosthesis[J].Ann Thorac Surg,2006,81(1):279-285.
|
34 |
Scarnecchia E,Liparulo V,Capozzi R,et al.Chest wall resection and reconstruction for tumors: analysis of oncological and functional outcome[J].J Thorac Dis,2018,10(Suppl 16):S1855-S1863.
|
35 |
Wiegmann B,Zardo P,Dickgreber N,et al.Biological materials in chest wall reconstruction: initial experience with the Peri-Guard Repair Patch[J].Eur J Cardiothorac Surg,2010,37(3):602-605.
|
36 |
Wang L,Huang L,Li X,et al.Three-Dimensional Printing PEEK Implant: A Novel Choice for the Reconstruction of Chest Wall Defect[J].Ann Thorac Surg,2019,107(3):921-928.
|
37 |
Kumar N,Malik PS,Bharati SJ,et al.Primary lung cancer with chest wall involvement: Outcomes of a multimodality management approach[J].Lung India,2021,38(4):338-342.
|
38 |
Sauerbier M,Dittler S,Kreutzer C.Microsurgical chest wall reconstruction after oncologic resections[J].Semin Plast Surg,2011,25(1):60-69.
|
39 |
Brown LM,Cooke DT,David EA.Adjuvant Chemotherapy Does Not Improve Survival for Lung Cancer With Chest Wall Invasion[J].Ann Thorac Surg,2017,104(6):1798-1804.
|
40 |
Berriochoa C,Videtic GM,Woody NM,et al.Stereotactic Body Radiotherapy for T3N0 Lung Cancer With Chest Wall Invasion[J].Clin Lung Cancer,2016,17(6):595-601.
|
41 |
Muñoz-Largacha JA,Rao SR,Brinckerhoff LH,et al.Induction chemoradiation is associated with improved survival in chest wall invasion lung cancer[J].Tumori,2019,105(4):331-337.
|
42 |
Kennedy WR,Gabani P,Nikitas J,et al.Treatment of T3N0 non-small cell lung cancer with chest wall invasion using stereotactic body radiotherapy[J].Clin Transl Radiat Oncol,2019,16:1-6.
|
43 |
Stoelben E,Ludwig C.Chest wall resection for lung cancer: indications and techniques[J].Eur J Cardiothorac Surg,2009,35(3):450-456.
|
44 |
Wang Meina,Herbst Roy S.,Boshoff Chris,等.非小细胞肺癌的个体化治疗进展[J].中国肺癌杂志,2022,25(3):219-236.
|
45 |
Zhong WZ,Chen KN,Chen C,et al.Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103):A Randomized Phase II Study[J].J Clin Oncol,2019,37(25):2235-2245.
|
46 |
Liu SY,Zhang JT,Zeng KH,et al.Perioperative targeted therapy for oncogene-driven NSCLC[J/OL].Lung Cancer,2022,[Epub ahead of print].
|
47 |
Sun L,Guo YJ,Song J,et al.Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC:A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials[J].Front Oncol,2020,10:586596.
|
48 |
Zhao Z,Gao Y,Xue Q,et al.Safety and Efficacy of Neoadjuvant Immune Checkpoint Inhibitor Therapy in Patients with Resectable Non-small-Cell Lung Cancer:A Systematic Review[J].Target Oncol,2021,16(4):425-434.
|
49 |
Yeh J,Marrone KA,Forde PM.Neoadjuvant and consolidation immuno-oncology therapy in stage III non-small cell lung cancer[J].J Thorac Dis,2018,10(Suppl 3):S451-S459.
|
50 |
Wang J,Li J,Cai L,et al.The safety and efficacy of neoadjuvant programmed death 1 inhibitor therapy with surgical resection in stage IIIA non-small cell lung cancer[J].Ann Transl Med,2021,9(6):486.
|
51 |
Janjigian YY,Shitara K,Moehler M,et al.First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial[J].Lancet,2021,398(10294):27-40.
|
52 |
Douillard JY,Rosell R,De Lena M,et al.Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial[J].Int J Radiat Oncol Biol Phys,2008,72(3):695-701.
|
53 |
Le Pechoux C,Pourel N,Barlesi F,et al.Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART):an open-label, randomised, phase 3 trial[J].Lancet Oncol,2022,23(1):104-114.
|
54 |
朱晓霞,苏俊威.精确术后放疗对pⅢA-N2非小细胞肺癌患者在完全切除和辅助化疗后生存和失败模式的影响[J].循证医学,2020,20(6):325-328.
|
55 |
Gao SJ,Corso CD,Blasberg JD,et al.Role of Adjuvant Therapy for Node-Negative Lung Cancer Invading the Chest Wall[J].Clin Lung Cancer,2017,18(2):169-177.e4.
|
56 |
Yue D,Xu S,Wang Q,et al.Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN):a randomised, open-label, phase 2 trial[J].Lancet Respir Med,2018,6(11):863-873.
|
57 |
Chen CY,Fares CM,Shin DS.Osimertinib as neoadjuvant therapy in a patient with stage IIIA non-small cell lung cancer: a case report[J].J Med Case Rep,2021,15(1):216.
|
58. |
Felip E,Altorki N,Zhou C,et al.Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010):a randomised, multicentre, open-label, phase 3 trial[J].Lancet,2021,398(10308):1344-1357.
|